FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990103329> ?p ?o ?g. }

• W1990103329 endingPage "1422" @default.
• W1990103329 startingPage "1417" @default.
• W1990103329 abstract "<h3>Abstract</h3> <b>Objective:</b> To analyse the cost effectiveness of a national programme to screen blood donors for infection with the human T cell leukaemia/lymphoma virus. <b>Design:</b> Three models for calculating the costs and benefits of screening were developed. The first model analysed the cost of continuously testing all donations; the second analysed the cost of initially testing new blood donors and then retesting them after five years; the third analysed the cost of testing donors only at the time of their first donation. Patients who had received blood components from donors confirmed to be infected with the virus were offered testing. <b>Setting:</b> Sweden. <b>Main outcome measures:</b> Prevalence of infection with the virus among blood donors, the risk of transmission of the virus, screening costs, and the outcome of infection. <b>Results:</b> 648 497 donations were tested for the virus; 1625 samples tested positive by enzyme linked immunosorbent assay. 6 were confirmed positive by western blotting. The prevalence of infection with the virus was 2/100 000 donors. 35 patients who had received blood infected with the virus were tested; 3 were positive. The cost of testing every donation was calculated to be $3.02m (£1.88m); this is 18 times higher than the cost of testing new donors only, and only 1 additional positive donor would be discovered in 7 years. Regardless of the model used, screening was estimated to prevent only 1 death every 200 years at a minimum cost of $36m (£22.5m). <b>Conclusion:</b> Based on these estimates the Swedish National Board of Health and Welfare decided that only new blood donors would be screened for infection with the virus. <h3>Key messages</h3> The human T cell leukaemia/lymphoma virus is primarily sexually transmitted; it may also be transmitted through blood transfusions Infection with the virus may cause adult T cell leukaemia/lymphoma or tropical spastic paraparesis Many countries including Sweden have begun screening blood donors for the virus; however a low prevalence of infection in non-endemic areas a low risk of developing adult T cell leukaemia/lymphoma in people infected with the virus a long incubation period and the older age of most transfusion recipients make screening costly Three models of screening were compared: testing every donation, testing new donors and then retesting them after five years, and testing new donors only Regardless of the model used screening in Sweden would only prevent one death every 200 years at a minimum cost of $36m (£22.5m)" @default.
• W1990103329 created "2016-06-24" @default.
• W1990103329 creator A5004616421 @default.
• W1990103329 creator A5017481679 @default.
• W1990103329 creator A5017981821 @default.
• W1990103329 creator A5021471714 @default.
• W1990103329 creator A5025129999 @default.
• W1990103329 creator A5063465178 @default.
• W1990103329 creator A5064404099 @default.
• W1990103329 creator A5069230910 @default.
• W1990103329 creator A5071625584 @default.
• W1990103329 creator A5073055510 @default.
• W1990103329 creator A5053178585 @default.
• W1990103329 date "1998-05-09" @default.
• W1990103329 modified "2023-10-16" @default.
• W1990103329 title "Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis" @default.
• W1990103329 cites W1975441750 @default.
• W1990103329 cites W1978771608 @default.
• W1990103329 cites W1979637191 @default.
• W1990103329 cites W1981630138 @default.
• W1990103329 cites W2001274033 @default.
• W1990103329 cites W2001389341 @default.
• W1990103329 cites W2005405772 @default.
• W1990103329 cites W2013551493 @default.
• W1990103329 cites W2029643271 @default.
• W1990103329 cites W2066718300 @default.
• W1990103329 cites W2073124121 @default.
• W1990103329 cites W2077628697 @default.
• W1990103329 cites W2079504599 @default.
• W1990103329 cites W2086143621 @default.
• W1990103329 cites W2087462453 @default.
• W1990103329 cites W2092453476 @default.
• W1990103329 cites W2100778918 @default.
• W1990103329 cites W2132822179 @default.
• W1990103329 cites W2134895397 @default.
• W1990103329 cites W4233631472 @default.
• W1990103329 cites W4247569094 @default.
• W1990103329 cites W4300457278 @default.
• W1990103329 doi "https://doi.org/10.1136/bmj.316.7142.1417" @default.
• W1990103329 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/28538" @default.
• W1990103329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9572750" @default.
• W1990103329 hasPublicationYear "1998" @default.
• W1990103329 type Work @default.
• W1990103329 sameAs 1990103329 @default.
• W1990103329 citedByCount "35" @default.
• W1990103329 countsByYear W19901033292012 @default.
• W1990103329 countsByYear W19901033292013 @default.
• W1990103329 countsByYear W19901033292014 @default.
• W1990103329 countsByYear W19901033292015 @default.
• W1990103329 countsByYear W19901033292016 @default.
• W1990103329 countsByYear W19901033292017 @default.
• W1990103329 countsByYear W19901033292019 @default.
• W1990103329 countsByYear W19901033292023 @default.
• W1990103329 crossrefType "journal-article" @default.
• W1990103329 hasAuthorship W1990103329A5004616421 @default.
• W1990103329 hasAuthorship W1990103329A5017481679 @default.
• W1990103329 hasAuthorship W1990103329A5017981821 @default.
• W1990103329 hasAuthorship W1990103329A5021471714 @default.
• W1990103329 hasAuthorship W1990103329A5025129999 @default.
• W1990103329 hasAuthorship W1990103329A5053178585 @default.
• W1990103329 hasAuthorship W1990103329A5063465178 @default.
• W1990103329 hasAuthorship W1990103329A5064404099 @default.
• W1990103329 hasAuthorship W1990103329A5069230910 @default.
• W1990103329 hasAuthorship W1990103329A5071625584 @default.
• W1990103329 hasAuthorship W1990103329A5073055510 @default.
• W1990103329 hasBestOaLocation W19901033291 @default.
• W1990103329 hasConcept C119599485 @default.
• W1990103329 hasConcept C126322002 @default.
• W1990103329 hasConcept C127413603 @default.
• W1990103329 hasConcept C159047783 @default.
• W1990103329 hasConcept C162324750 @default.
• W1990103329 hasConcept C203014093 @default.
• W1990103329 hasConcept C2522874641 @default.
• W1990103329 hasConcept C2775933685 @default.
• W1990103329 hasConcept C2779338263 @default.
• W1990103329 hasConcept C2983335822 @default.
• W1990103329 hasConcept C2993617979 @default.
• W1990103329 hasConcept C42475967 @default.
• W1990103329 hasConcept C50522688 @default.
• W1990103329 hasConcept C71924100 @default.
• W1990103329 hasConcept C761482 @default.
• W1990103329 hasConceptScore W1990103329C119599485 @default.
• W1990103329 hasConceptScore W1990103329C126322002 @default.
• W1990103329 hasConceptScore W1990103329C127413603 @default.
• W1990103329 hasConceptScore W1990103329C159047783 @default.
• W1990103329 hasConceptScore W1990103329C162324750 @default.
• W1990103329 hasConceptScore W1990103329C203014093 @default.
• W1990103329 hasConceptScore W1990103329C2522874641 @default.
• W1990103329 hasConceptScore W1990103329C2775933685 @default.
• W1990103329 hasConceptScore W1990103329C2779338263 @default.
• W1990103329 hasConceptScore W1990103329C2983335822 @default.
• W1990103329 hasConceptScore W1990103329C2993617979 @default.
• W1990103329 hasConceptScore W1990103329C42475967 @default.
• W1990103329 hasConceptScore W1990103329C50522688 @default.
• W1990103329 hasConceptScore W1990103329C71924100 @default.
• W1990103329 hasConceptScore W1990103329C761482 @default.
• W1990103329 hasIssue "7142" @default.
• W1990103329 hasLocation W19901033291 @default.

• next